For critically ill COVID-19 patients treated with extracorporeal membrane oxygenation (ECMO), the risk of death remains high—but is much lower than suggested by initial studies, according to a report published today by Annals of Surgery.
For critically ill COVID-19 patients treated with extracorporeal membrane oxygenation (ECMO), the risk of death remains high—but is much lower than suggested by initial studies, according to a report published today by Annals of Surgery.
